108 related articles for article (PubMed ID: 9987161)
21. Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.
Zhang Y; Pacheco S; Acuna CL; Switzer KC; Wang Y; Gilmore X; Harriman GR; Mbawuike IN
Immunology; 2002 Mar; 105(3):286-94. PubMed ID: 11918690
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
23. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms.
Metzger DW; McNutt RM; Collins JT; Buchanan JM; Van Cleave VH; Dunnick WA
Eur J Immunol; 1997 Aug; 27(8):1958-65. PubMed ID: 9295032
[TBL] [Abstract][Full Text] [Related]
25. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
[TBL] [Abstract][Full Text] [Related]
26. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
27. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
28. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization.
Hodge LM; Marinaro M; Jones HP; McGhee JR; Kiyono H; Simecka JW
Infect Immun; 2001 Apr; 69(4):2328-38. PubMed ID: 11254590
[TBL] [Abstract][Full Text] [Related]
30. Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12.
Baca-Estrada ME; Foldvari M; Snider M
J Interferon Cytokine Res; 1999 May; 19(5):455-62. PubMed ID: 10386857
[TBL] [Abstract][Full Text] [Related]
31. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
[TBL] [Abstract][Full Text] [Related]
32. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
33. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation.
Jones HP; Hodge LM; Fujihashi K; Kiyono H; McGhee JR; Simecka JW
J Immunol; 2001 Oct; 167(8):4518-26. PubMed ID: 11591779
[TBL] [Abstract][Full Text] [Related]
34. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
35. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
[TBL] [Abstract][Full Text] [Related]
36. Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
Ren ST; Zhang XM; Sun PF; Sun LJ; Guo X; Tian T; Zhang J; Guo QY; Li X; Guo LJ; Che J; Wang B; Zhang H
PLoS One; 2017; 12(1):e0169501. PubMed ID: 28052136
[TBL] [Abstract][Full Text] [Related]
37. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
Int Immunol; 1999 Oct; 11(10):1717-24. PubMed ID: 10508191
[TBL] [Abstract][Full Text] [Related]
38. Application of pH-sensitive fusogenic polymer-modified liposomes for development of mucosal vaccines.
Watarai S; Iwase T; Tajima T; Yuba E; Kono K; Sekiya Y
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):62-72. PubMed ID: 23790647
[TBL] [Abstract][Full Text] [Related]
39. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
Vadolas J; Davies JK; Wright PJ; Strugnell RA
Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
[TBL] [Abstract][Full Text] [Related]
40. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J
Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
